Endologix Inc. (NSDQ:ELGX) signed a deal to acquire Nellix Inc. for $15 million in stock, the company said today.
The Irvine, California-based developer of aortic disorder devices hopes the deal increases its share of the aortic repair market.
Palo Alto, California-based Nellix is developing an endograft for the treatment of abdominal aortic aneurysms, and the device would complement Endologix‘s flagship endovascular stent graft product, the Powerlink System, according to the company.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
“We believe Nellix is the most revolutionary [endovascular aortic repair] technology in the world and will help position Endologix as the innovation leader in aortic aneurysm treatment. Nellix has developed a new technology that will allow more physicians to treat more patients than with any of the existing devices,” ELGX CEO John McDermott said in prepared remarks.
So far, Nellix’s clinical results from implant patients with up to two years follow-up have not had any abdominal aortic aneurysms-related mortalities, aneurysm ruptures, surgical conversions or stent graft migrations.
The agreement between the two companies stipulates additional milestone-based, stock payments of up to $39 million. The deal also includes a commitment for a $15 million equity investment in Endologix from Nellix’s majority shareholder Essex Woodlands Health Ventures, Endologix said.
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.